Diagnostic vs therapeutic splenectomy: the trend in tertiary center


  • Abinaya R. Nadarajan Department of General Surgery, Christian Medical College and Hospital, Vellore, Tamil Nadu, India
  • Beulah Roopavathana S. Department of General Surgery, Christian Medical College and Hospital, Vellore, Tamil Nadu, India
  • Suchita Chase Department of General Surgery, Christian Medical College and Hospital, Vellore, Tamil Nadu, India
  • Sukria Nayak Department of General Surgery, Christian Medical College and Hospital, Vellore, Tamil Nadu, India




Diagnostic, ITP, Splenectomy, Therapeutic


Background: The recent trend being towards spleen preservation, it is necessary to critically analyse the indications for splenectomy and assess if the desired preoperative outcomes are achieved by splenectomy.

Methods: This was a retrospective study and patients who underwent elective or emergency splenectomy for various indications in the surgical unit from September 2011 to July 2016 were included. The data was collected from patients records and hospital electronic database.

Results: From September 2011 to July 2016, totally 68 patients underwent splenectomy.  The indications for therapeutic intervention were splenic abscess (2), splenic cyst (4), trauma (8), ITP (20) and anemia (12). The indications for diagnostic splenectomy were pyrexia of unknown origin in 7 patients and splenomegaly with anemia or pancytopenia in 15 patients. The objective of the operation was achieved in 43 patients (63%). The success rate for each indication: diagnosis (12 of 22 patients, 55%), thrombocytopenia (12 of 20 patients, 60%), anemia (5 of 12 patients, 42%) and as a primary treatment (12 of 14 patients, 86%). Postoperative morbidity within 30days of surgery was seen in 9 patients (13%) and 2 patients (3%) died within 30days of surgery.

Conclusions: The indication for splenectomy should be individualized after exploring all other treatment options and based on outcome.


Weledji EP. Benefits and risks of splenectomy. Inter J Surg. 2014;12(2):113-9.

Edgren G, Almqvist R, Hartman M, Utter GH. Splenectomy and the risk of sepsis: a population-based cohort study. Ann Surg. 2014;260(6):1081-7.

Lin JN, Lin CL, Lin MC, Lai CH, Lin HH, Yang CH, et al. Increased risk of hemorrhagic and ischemic strokes in patients with splenic injury and splenectomy: a nationwide cohort study. Med. 2015;94(35).

Browning MG, Bullen N, Nokes T, Tucker K, Coleman M. The evolving indications for splenectomy. Brit J Haematol. 2017;177(2):321-4.

Pata G, Damiani E, Tognali D, Solaini L, Watt J, Ragni F. Outcomes of open splenectomy for hematologic malignancy with splenomegaly: a contemporary perspective. Am Surg. 2015;81(4):414-20.

Neuwirth MG, Bartlett EK, Newton AD, Fraker DL, Kelz RR, Roses RE, et al. Morbidity and mortality after total splenectomy for lymphoid neoplasms. J Surg Res. 2016;205(1):155-62.

Leone G, Pizzigallo E. Bacterial infections following splenectomy for malignant and nonmalignant hematologic diseases. Mediterranean J Hematol Infectious Dis. 2015;7(1).

Boyle S, White RH, Brunson A, Wun T. Splenectomy and the incidence of venous thromboembolism and sepsis in patients with immune thrombocytopenia. Blood. 2013:4782-90.

Rodeghiero F, Ruggeri M. Short‐and long‐term risks of splenectomy for benign haematological disorders: should we revisit the indications?. Brit J Haematol. 2012;158(1):16-29.

Wang L, Xu J, Li F, Zhan H, Liu H, Chen W, et al. Partial splenectomy is superior to total splenectomy for selected patients with hemangiomas or cysts. World J Surg. 2017;41(5):1281-6.

Kristinsson SY, Gridley G, Hoover RN, Check D, Landgren O. Long-term risks after splenectomy among 8,149 cancer-free American veterans: a cohort study with up to 27years follow-up. haematol. 2014;99(2):392-8.

Zheng D, Huang CS, Huang SB, Zheng CX. Laparoscopic splenectomy for primary immune thrombocytopenia: Current status and challenges. World J Gastrointestinal Endoscopy. 2016;8(17):610.

Matharoo GS, Afthinos JN, Gibbs KE. Trends in splenectomy: where does laparoscopy stand?. JSLS: J Soc Laparo-endoscopic Surg. 2014;18(4).

Kikuchi K, Miyakawa Y, Ikeda S, Sato Y, Takebayashi T. Cost-effectiveness of adding rituximab to splenectomy and romiplostim for treating steroid-resistant idiopathic thrombocytopenic purpura in adults. BMC Health Services Res. 2015;15(1):2.

Uranüs S, Sill H. Splenectomy for hematological disorders. In: Holzheimer RG, Mannick JA, eds. Surgical Treatment: Evidence-Based and Problem-Oriented. Munich: Zuckschwerdt; 2001. Available at: https://www.ncbi.nlm.nih.gov/books/NBK6913/.

Uranues S, Grossman D, Ludwig L, Bergamaschi R. Laparoscopic partial splenectomy. Surg Endoscopy. 2007;21(1):57-60.






Original Research Articles